GLP-1anddiabetes. Glucagon-like peptide-1 (GLP-1) is a 30- or 31-amino-acid-long peptide hormone deriving from tissue-specific posttranslational processing of the proglucagon peptide.
Dec 10, 2025 ·Evidence-based review onGLP-1medications and how they affect triathlon training, performance, fuelling, and recovery. Includes key risks and insights every enduranceathleteshould know.
AthletesandGLP-1s: What You Need to Know How semaglutide and tirzepatide affectmusclemass, endurance, recovery, and performance. WADA status, professionalathleteconsiderations, and sport-specific guidance.
Jan 13, 2026 ·Superstarathleteshave been promoting the blockbusterGLP-1weight loss and diabetes meds, a head-scratching move that some experts are hailing as a game-changer.
The rapid ascent ofGLP-1agonists for athletic performance and body composition marks one of the most significant—and controversial—shifts in sports science in a generation. But what happens when a medication designed for metabolic health collides with the ruthless demands ofelitecompetition?
Mar 24, 2026 ·Because of this intersection of sport, pharmacology, community practice, and lived experience, I approachGLP-1use inathleteswith both optimism and vigilance—recognizing therapeutic potential while remaining protective of metabolic resilience, mental health, and long-term performance sustainability.
Quora is a place to gain and share knowledge. It's a platform to ask questions and connect with people who contribute unique insights and quality answers. This empowers people to learn from each other and tobetterunderstand the world.
Eliteathletes, including Tom Brady, are promotingGLP-1weight-loss drugs like Ozempic and Wegovy. Here’s what it means for health, culture, and consumers.
